Antiviral Properties of Brassinosteroids

Brassinosteroids: Practical Applications in Agriculture and Human Health

Volumn , Issue , 2012, Pages 57-71

  Wachsman, Mónica B ^a   Castilla, Viviana ^a  

^a Laboratorio de Virologia Ciudad Autonoma de Buenos Aires   (Argentina)

Author keywords

Herpes simplex virus; Jun n virus; Measles virus; Poliovirus; Ribavirin; Vesicular stomatitis

Indexed keywords

EID: 84884063037     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805298111201010057     Document Type: Chapter

References (46)

1. Elion, GB. Mechanism of action and selectivity of acyclovir. Am J Med 1982; 73, (Suppl. 1A), 7-13.
2. De Clercq E. Highlights in the discovery of antiviral drugs: A personal retrospective. J Med Chem 2010; 53: 1438-50.
3. De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents 2009; 33: 307-20.
4. Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Res 1999; 44: 79-102.
5. Shigeta S. Approaches to antiviral chemotherapy for acute respiratory infections. Antiviral Chem Chemother 1998; 9: 93-107.
6. Dixon, R. A. Natural products and plant disease resistance. Nature 2001; 411: 843-7.
7. Grove MD, Spencer GF, Rohwedder WK, et al. Brassinolide, a plant growth-promoting steroid isolated from Brassica napus pollen. Nature 1979; 281: 216-7.
8. Mandava NB. Plant growth-promoting brassinosteroids. Ann Rev Plant Physiol Plant Mol Biol 1988; 39: 23-52.
9. Bajguz A, Tretyn A. The chemical characteristic and distribution of brassinosteroids in plants. Phytochem 2003; 62: 1027-46.
10. Kohen F F, Gunasekera M, Cross S S. New antiviral sterol disulfate ortho esters from the marine sponge Petrosia weinbergi. J Org Chem 1991; 56: 1322-5.
11. Sun H H, Cross S S, Gunasekera M, Koehn F F. Weinbersterol disulfates A and B, antiviral steroid sulfates from the sponge Petrosia weinbergi. Tetrahedron 1991; 47: 1185-90.
12. Comin M J, Maier M S, Roccatagliata A J, Pujol C A, Damonte, E B. Evaluation of the antiviral activity of natural sulfated polyhydroxysteroids and their synthetic derivatives and analogs. Steroids 1999; 64: 335-40.
13. Arthan D, Svasti J, Kittakoop P, Pittayakhachonwut D, Tanticharoen M, Thebtaranonth Y. Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum. Phytochem 2002; 59: 459-63.
14. Acosta E G, Bruttomesso A C, Bisceglia J A, Wachsman M B, Galagovsky L R, Castilla V. Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro. Virus Res 2008; 135: 203-12.
15. Romanutti C, Bruttomesso A C, Castilla V, Bisceglia J A, Galagovsky L R, Wachsman M B. In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus. Vet J 2009; 182:327-35.
16. Romanutti C, Bruttomesso A C, Castilla V, Galagovsky L R, Wachsman M B. Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives. Chemotherapy 2010; 56:158-65.
17. Henderson E, Yang J, Schwartz A: Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication. AIDS Res Human Retrovir 1992; 8: 625-31.
18. Diallo K, Loemba H, Oliveira M, Mavoungou D D, Wainberg M A. Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by immunor (IM28), a new analog of dehydroepiandrosterone. Nucleos Nucleot Nucleic Acids 2000; 19: 2019-24.
19. Mavoungou D, Poaty-Mavoungou V, Akoume M, Ongali B, Mavoungou E: Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28). Virol J 2005; 11: 9-10.
20. Chang CC, Ou YC, Rang SL, Chen CJ. Antiviral effect of dehydroepiandrosterone on Japonese Encephalitis virus infection. J Gen Virol 2005; 86: 2513-23.
21. Wachsman MB, López EM, Ramírez, JA, Galagovsky LR, Coto CE. Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antivir Chem Chemother 2000; 11: 71-7.
22. Wachsman MB, Ramirez JA, Galagovsky LR, Coto CE Antiviral activity of brassinosteroids derivatives against measles virus in cell cultures. Antivir Chem Chemother 2002; 13: 61-6.
23. Talarico LB, Ramirez JA, Galagovsky LR, Wachsman MB. Structure-activity relationship studies in a set of new brassinosteroid derivatives assayed against herpes simplex virus type 1 and 2 in cell cultures. Med Chem Res 2002, 11: 434-44.
24. Wachsman MB, Castilla V, Talarico LB, Ramirez JA, Galagovsky LR, Coto CE. Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23-trihydroxystigmastan-6-one in vitro. Int J Antimicrob Agents 2004; 23: 524-7.
25. Wachsman MB, Ramírez JA, Talarico LB, Galagovsky LR, Coto CE. Antiviral activity of natural and synthetic brassinosteroids. Curr Med Chem.- Anti-Infective Agents 2004; 3: 163-79.
26. Castilla V, Ramírez JA, Coto CE. Plant and animal steroids a new hope to search for antiviral agents. Curr Med Chem 2010; 17: 1858-73.
27. Cutts FT, Henao-Restrepo AM, Olive JM. Measles elimination: progress and challenges. Vaccine 1999; 17: S47-S52.
28. Weissenbacher MC, Laguens RP, Coto CE. Argentine hemorrhagic fever. Curr Top Microbiol Immunol 1987; 134: 79-116.
29. Collett MS, Neyts J, Modlin JF. A case for developing antiviral drugs against polio. Antivir Res 2008; 79:179-87.
30. Rodriguez LL. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res 2002; 85: 211-9.
31. Whitley RJ, Roizman B. Herpes simplex virus infections. The Lancet 2001; 357: 1513-8.
32. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. J Immunol Methods 1986; 89: 271-7.
33. Romanutti C, Castilla V, Coto CE, Wachsman MB. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells. Int J Antimicrob Agents 2007; 29: 311-6.
34. Talarico LB, Castilla V, Ramirez JA, Galagovsky LR, Wachsman M B. Synergistic in vitro interactions between (22S,23S)-3β-bromo-5α,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1. Chemotherapy 2006; 52: 38-42.
35. Castilla V, Larzábal M, Sgalippa NA, Wachsman M B, Coto C E. Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication. Antiviral Res 2005; 68: 88-95.
36. Khripach V, Zhabinskii V, De Groot A. Twenty years of brassinosteroids: Steroidal plant hormones warrant better crops for the XXI century. Ann Bot 2000; 86: 441-7.
37. Michelini F M, Ramírez JA, Berra A, Galagovsky LR, Alché L E. In vitro and in vivo antiherpetic activity of three new synthetic brassinosteroid analogues. Steroids 2004; 69: 713-20.
38. Michelini FM, Berra A, Alché LE. The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in mice. J Steroid Biochem Mol Biol 2008; 108: 164-70.
39. Michelini FM, Ramírez JA, Berra A, Galagovsky LR, Alché L E. Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives. J. Steroid Biochem Mol Biol 2008; 111: 111-6.
40. Ramírez JA, Bruttomesso AC, Michelini FM, Acebedo SL, Alché LE, Galagovsky LR. Syntheses of immunomodulating androstanes and stigmastanes: comparison of their TNF-alpha inhibitory activity. Bioorg Med Chem 2007; 15: 7538-44.
41. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354-7.
42. Schaller H. The role of sterols in plant growth and development. Prog Lipid Res 2003: 42:163-75.
43. Karlova R, de Vries S C. Advances in understanding brassinosteroid signaling. Sci STKE; 2006: 354 pe36.
44. Ashida K, Goto K, Zhao Y, et al. Dehydroepiandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase. Biochim Biophys Acta 2005; 1728:84-94.
45. Ziegler CG, Sicard F, Sperber S, Ehrhart-Bornstein M, Bornstein S R, Krug A W. DHEA reduces NGF-mediated cell survival in serum-deprived PC12 cells. Ann N Y Acad Sci 2006; 1073: 306-11.
46. Schümann M, Dobbelstein M. Adenovirus induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny. Cancer Res 2006; 66: 1282-8.